Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2107-0180
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation ; volume:41 ; number:4 ; day:7 ; month:2 ; year:2015 ; pages:331-338 ; date:8.2016
European journal of drug metabolism and pharmacokinetics ; 41, Heft 4 (7.2.2015), 331-338, 8.2016
- Creator
-
Sobiak, Joanna
- Contributor
-
Resztak, Matylda
Głyda, Maciej
Szczepaniak, Paulina
Chrzanowska, Maria
SpringerLink (Online service)
- DOI
-
10.1007/s13318-015-0262-9
- URN
-
urn:nbn:de:1111-2016072241115
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sobiak, Joanna
- Resztak, Matylda
- Głyda, Maciej
- Szczepaniak, Paulina
- Chrzanowska, Maria
- SpringerLink (Online service)
Other Objects (12)
Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients